Screening for down syndrome in the United States: Results of surveys in 2011 and 2012

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 7, 2013, Pages 921-926

  Palomaki, Glenn E ^a   Knight, George J ^a   Ashwood, Edward R ^b   Best, Robert G ^c   Haddow, James E ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; DOWN SYNDROME; FEMALE; HEALTH CARE DELIVERY; HUMAN; MASS SCREENING; METHODOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRE; STATISTICS; UNITED STATES;

ADULT; DELIVERY OF HEALTH CARE; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTERS; PRENATAL DIAGNOSIS; QUESTIONNAIRES; UNITED STATES;

EID: 84879652548     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0319-CP     Document Type: Article

References (22)

1. Wald NJ, Cuckle H, Brock JH, Peto R, Polani PE, Woodford FP. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy: report of U.K. collaborative study on alphafetoprotein in relation to neural-tube defects. Lancet. 1977;1(8026):1323-1332.
2. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet. 1984;1(8383):926-929.
3. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984;148(7):886-894.
4. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol. 1988;95(4):330-333.
5. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987;7(9):623-630.
6. Ozturk M, Milunsky A, Brambati B, Sachs ES, Miller SL, Wands Jr. Abnormal maternal serum levels of human chorionic gonadotropin free subunits in trisomy 18. Am J Med Genet. 1990;36(4):480-483.
7. Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP. Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies. Prenat Diagn. 1995;15(4):385-386.
8. Knight GJ, Palomaki GE, Neveux LM, Fodor KK, Haddow JE. hCG and the free β-subunit as screening tests for Down syndrome. Prenat Diagn. 1998;18(3): 235-245.
9. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ. 1988;297(6653):883-887.
10. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen. 2003;10(2):56-104.
11. Wald N, Stone R, Cuckle HS, et al. First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. BMJ. 1992;305(6844):28.
12. Spencer K, Macri JN, Aitken DA, Connor JM. Free beta-hCG as firsttrimester marker for fetal trisomy. Lancet. 1992;339(8807):1480.
13. Palomaki GE, Lambert-Messerlian GM, Canick JA. A summary analysis of Down syndrome markers in the late first trimester. Adv Clin Chem. 2007;43:177-210.
14. Szabo J, Gellen J. Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester. Lancet. 1990;336(8723):1133.
15. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med. 1999;341(7):461-467.
16. Knight GJ, Palomaki GE, Neveux LM, et al. Integrated serum screening for Down syndrome in primary obstetric practice. Prenat Diagn. 2005;25(12):1162- 1167.
17. Palomaki GE, Steinort K, Knight GJ, Haddow JE. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers. Obstet Gynecol. 2006;107(2, pt 1):367-375.
18. Palomaki GE, Knight GJ, Holman MS, Haddow JE. Maternal serum alphafetoprotein screening for fetal Down syndrome in the United States: results of a survey. Am J Obstet Gynecol. 1990;162(2):317-321.
19. Palomaki GE, Knight GJ, McCarthy J, Haddow JE, Eckfeldt JH. Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey. Am J Obstet Gynecol. 1993;169(6):1558-1562.
20. Palomaki GE, Knight GJ, Lambert-Messerlian G, Canick JA, Haddow JE. Four years' experience with an interlaboratory comparison program involving first-trimester markers of Down syndrome. Arch Pathol Lab Med. 2010;134(11): 1685-1691.
21. Kazerouni NN, Currier B, Malm L, et al. Triple-marker prenatal screening program for chromosomal defects. Obstet Gynecol. 2009;114(1):50-58.
22. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109(1):217-227.